Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to vero cells

Journal of Virology

Volumn 75, Issue 16, 2001, Pages 7769-7773

  Crill, W D ^a   Roehrig, J T ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

ARTICLE; BINDING SITE; DENGUE; DENGUE VIRUS; FLAVIVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; RECEPTOR BINDING; STRAIN DIFFERENCE; STRUCTURE ACTIVITY RELATION; VERO CELL; VIRUS ADSORPTION; VIRUS INFECTIVITY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; DENGUE VIRUS; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 0034899311     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.16.7769-7773.2001     Document Type: Article

References (25)

1. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E
2. Correlation of E protein binding with cell susceptibility to dengue 4 virus infection
3. Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein
4. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
5. Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments
6. A new mechanism for the neutralization of enveloped viruses by antiviral antibody
7. Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2
8. Antibody-induced conformational changes result in enhanced avidity of antibodies to different antigenic sites on the tick-borne encephalitis virus glycoprotein
9. Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies
10. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: Monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence
11. Analysis of the steps involved in dengue virus entry into host cells
12. Construction of infectious cDNA clones for dengue 2 virus: Strain 16681 and its attenuated vaccine derivative, strain PDK-53
13. Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry
14. Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site
15. The molecular basis of virulence of the encephalitic flaviviruses
16. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
17. Flaviviridae: The viruses and their replication
18. Immunochemistry of the dengue viruses
19. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica
20. Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation
21. In vitro mechanisms of monoclonal antibody neutralization of alphaviruses
22. Alteration of virus entry mode: A neutralization mechanism for dengue-2 virus
23. Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody
24. Mutagenesis of the RGD motif in the yellow fever virus 17D envelope protein
25. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid